6 completed, 1 active not recruiting, 1 terminated, 1 unknown. 3 Not applicable, 3 Phase 4, 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 3 |
| Phase 4 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 2 | Active not recruiting 1, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow haloperidol decanoate: new trials by email Literature Review of haloperidol decanoate trials Research Report on haloperidol decanoate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reducing the Burden of Chronic Psychotic Disorders in Tanzania (CAPACITY) Customized Adherence Enhancement, Haloperidol Decanoate - Schizophrenia, Medication Nonadherence | Phase 3 | Completed | Case Western Reserve University | 22 | 2019-11-05 | 2021-10-12 |
| Antipsychotic Effects of Sorghum Bicolor (JOBELYN) in the Treatment of Schizophrenia Jobelyn, Haloperidol - Schizophrenia and Disorders With Psychotic Features | Phase 1 / Phase 2 | Unknown | Federal Neuro-Psychiatric Hospital, Yaba | 100 | 2017-06-01 | 2017-02-16 |
| A Concierge Model of CAE Plus LAI in Individuals With Schizophrenia at Risk for Treatment Non-adherence and Homelessness CAE-L - Psychotic Disorders, Schizophrenia | Not applicable | Completed | University Hospitals Cleveland Medical Center | 30 | 2014-05-01 | 2019-12-09 |
| Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer Lorazepam, Placebo, Haloperidol decanoate - Advanced Cancers | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 93 | 2014-01-01 | 2026-07-17 |
| A Comparison of Long-acting Injectable Medications for Schizophrenia haloperidol decanoate, paliperidone palmitate - Schizophrenia, Schizoaffective Disorder | Phase 4 | Completed | New York State Psychiatric Institute | 311 | 2011-03-01 | 2016-10-21 |
| Preventing ICU Subsyndromal Delirium Conversion to Delirium With Haloperidol Haloperidol decanoate, Placebo - Subsyndromal Delirium | Phase 4 | Completed | Northeastern University | 68 | 2010-09-01 | 2017-04-14 |
| Customized Adherence Enhancement Plus Long-acting Injectable Antipsychotic haloperidol decanoate, haloperidol, Customized Adherence Enhancement - Patient Noncompliance | Not applicable | Completed | University Hospitals Cleveland Medical Center | 30 | 2010-06-01 | 2014-12-30 |
| Lamictal TM, Haloperidol Decanoate in Schizophrenia Lamictal TM, Haloperidol Decanoate - Schizophrenia | Phase 4 | Terminated | Central Mental Clinic for Outpatients of Baku City | 335 | 2005-01-01 | 2009-07-28 |
| Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective Disorder quetiapine, haloperidol decanoate - Schizophrenia, Schizoaffective Disorder | Not applicable | Completed | US Department of Veterans Affairs | 1997-04-01 | 2009-01-21 |
Schizophrenia (6) · Psychotic Disorders (4) · Delirium (2) · Medication Adherence (2) · Hematologic Neoplasms (1) · Neurotoxicity Syndromes (1) · Patient Compliance (1) · Schizophrenia Spectrum and Other Psychotic Disorders (1)
University Hospitals Cleveland Medical Center (2) · Case Western Reserve University (1) · Central Mental Clinic for Outpatients of Baku City (1) · Federal Neuro-Psychiatric Hospital, Yaba (1) · M.D. Anderson Cancer Center (1) · New York State Psychiatric Institute (1) · Northeastern University (1) · US Department of Veterans Affairs (1)
United States (6) · Azerbaijan (1) · Nigeria (1) · Tanzania (1)
Martha Sajatovic, MD (3) · David Hui, MD (1) · Greg Schumaker, MD (1) · John W Devlin, PharmD (1) · Joseph P McEvoy, MD (1) · Moses Ojo, M.D. (1) · Nadir A Aliyev, PHD, MD (1) · Scott Stroup, MD, MPH (1)
PMID 24434094, PMID 24846035, PMID 27247177, PMID 28975307, PMID 30549494, PMID 35086504
R01MH081107 (1), R15AG034915 (1), R21CA186000 (1), R21MH114700 (1)